Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.06% |
| 2 | Consumer Discretionary | 1.41% |
| 3 | Healthcare | 0.83% |
| 4 | Financials | 0.79% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
PUT
TG Therapeutics
TGTX
$8.48B
| $20.5M | ﹤0.01% |
1,201,000
+180,000
| +18% | +$2.09M |
|
1777
PUT
Asana
ASAN
$2.18B
| $20.5M | ﹤0.01% |
1,078,200
-155,700
| -13% | -$3.03M |
|
1778
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$246M
| $20.5M | ﹤0.01% |
396,400
-33,600
| -8% | -$1.55M |
|
1779
CALL
AGNC Investment
AGNC
$12.9B
| $20.5M | ﹤0.01% |
2,088,800
-428,600
| -17% | -$3.77M |
|
|
BPMC
1780
PUT
DELISTED
Blueprint Medicines
BPMC
| $20.5M | ﹤0.01% |
222,100
-49,200
| -18% | -$3.19M |
|
1781
Target
TGT
$74.3B
| $20.5M | ﹤0.01% |
143,640
-534,816
| -79% | -$65.3M |
|
1782
PUT
Sociedad Química y Minera de Chile
SQM
$22.6B
| $20.4M | ﹤0.01% |
339,500
+52,200
| +18% | +$2.76M |
|
1783
QuantumScape Corp
QS
$3.58B
| $20.4M | ﹤0.01% |
2,938,557
-56,593
| -2% | -$356K |
|
1784
CALL
Symbotic
SYM
$5.25B
| $20.4M | ﹤0.01% |
397,600
+160,100
| +67% | +$7.02M |
|
1785
PUT
Lucid Motors
LCID
$2.07B
| $20.4M | ﹤0.01% |
484,080
+105,190
| +28% | +$4.72M |
|
1786
CALL
iShares Core S&P Total US Stock Market ETF
ITOT
$97B
| $20.4M | ﹤0.01% |
193,600
+107,900
| +126% | +$10.6M |
|
1787
Equifax
EFX
$22.5B
| $20.4M | ﹤0.01% |
82,372
-40,256
| -33% | -$8.17M |
|
1788
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $20.4M | ﹤0.01% |
228,700
-1,749,900
| -88% | -$147M |
|
1789
PUT
Vanguard High Dividend Yield ETF
VYM
$83.1B
| $20.4M | ﹤0.01% |
182,400
-34,800
| -16% | -$3.66M |
|
1790
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $20.3M | ﹤0.01% |
349,896
+264,960
| +312% | +$14.2M |
|
1791
Biogen
BIIB
$32.6B
| $20.3M | ﹤0.01% |
78,590
-33,487
| -30% | -$8.22M |
|
1792
CALL
ARK Genomic Revolution ETF
ARKG
$1.97B
| $20.3M | ﹤0.01% |
619,500
+307,300
| +98% | +$8.36M |
|
1793
PUT
Danaos Corp
DAC
$2.78B
| $20.3M | ﹤0.01% |
274,200
+162,800
| +146% | +$11.1M |
|
|
SWAV
1794
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $20.3M | ﹤0.01% |
106,500
-18,900
| -15% | -$3.57M |
|
1795
PUT
Maplebear
CART
$11.9B
| $20.3M | ﹤0.01% |
864,100
+545,200
| +171% | +$13.7M |
|
1796
CALL
ProShares UltraPro Short S&P 500
SPXU
$392M
| $20.3M | ﹤0.01% |
117,895
+16,545
| +16% | +$3.55M |
|
1797
Vanguard FTSE Europe ETF
VGK
$31.3B
| $20.2M | ﹤0.01% |
313,970
+110,745
| +54% | +$6.63M |
|
1798
Xylem
XYL
$26.3B
| $20.2M | ﹤0.01% |
177,012
+89,377
| +102% | +$8.92M |
|
1799
CALL
C.H. Robinson
CHRW
$16.8B
| $20.2M | ﹤0.01% |
233,800
-94,500
| -29% | -$7.92M |
|
1800
CALL
Allegro MicroSystems
ALGM
$6.98B
| $20.2M | ﹤0.01% |
667,000
+399,000
| +149% | +$11.4M |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.